FDA Adverse Event Malfunction Summary report: N

BD SYRINGE E/T

MDR report key: 8420424 · Received March 14, 2019

Report

Report Number
3003152976-2019-00204
Event Type
Malfunction
Date Received
March 14, 2019
Date of Event
February 20, 2019
Report Date
March 15, 2019
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
UDI-DI
30382903008668
PMA / PMN Number
K980987
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TW
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: IT HAS BEEN RECEIVED 6 PICTURES FOR INVESTIGATION. UPON VISUAL INSPECTION OF THE PICTURES RECEIVED, IT CAN BE OBSERVED A PARTICLE INSIDE THE SYRINGE. DHR OF LOT 1801288 HAS BEEN REVIEWED NOT FINDING ANY ANNOTATION OR DEVIATION REGARDING THE ALLEGED DEFECT. SINCE PHYSICAL SAMPLE HAS NOT BEEN RECEIVED, THE ROOT CAUSE OF THE ALLEGED DEFECT CANNOT BE DETERMINED. IT IS POSSIBLE THAT IF SYRINGE WAS FILLED WITH DRUG FROM A VIAL USING A NEEDLE, THIS PARTICLE COMES FROM THE RUBBER VIAL DUE TO CORING DEFECT (PARTICLE OF RUBBER DETACHED DUE TO NEEDLE PENETRATION). BUT SINCE THE PARTICLE CANNOT BE INSPECTED IT CANNOT BE CONFIRMED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BARREL OF A BD¿ SYRINGE E/T HAD BLACK SPOT INSIDE. CUSTOMER¿S VERBATIM: ¿60ML SYRINGE:THE BARREL HAS FOREIGN MATTER (BLACK SPOT).THE EVENT WAS FOUND IN DILUTING COSTLY DRUG (NT4400)¿.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE BARREL OF A BD¿ SYRINGE E/T HAD BLACK SPOT INSIDE. CUSTOMER¿S VERBATIM: ¿60ML SYRINGE:THE BARREL HAS FOREIGN MATTER (BLACK SPOT).THE EVENT WAS FOUND IN DILUTING COSTLY DRUG (NT4400).¿

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
216296 BD SYRINGE E/T HYPODERMIC SYRINGE FMF BECTON DICKINSON, S.A. 1801288 30382903008668

Patients

Seq Age Sex Outcome Treatment
1 Other